Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Sep 2009):

Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.

Full Abstract

Fragile X syndrome (FXS) results from a CGG-repeat expansion that triggers hypermethylation and silencing of the FMR1 gene. FXS is referred to as the most common form of inherited intellectual disability, yet its true incidence has never been measured directly by large population screening. Here, we developed an inexpensive and high-throughput assay to quantitatively assess FMR1 methylation in DNA isolated from the dried blood spots of 36,124 deidentified newborn males. This assay displays 100% specificity and 100% sensitivity for detecting FMR1 methylation, successfully distinguishing normal males from males with full-mutation FXS. Furthermore, the assay can detect excess FMR1 methylation in 82% of females with full mutations, although the methylation did not correlate with intellectual disability. With amelogenin PCR used for detecting the presence of a Y chromosome, this assay can also detect males with Klinefelter syndrome (KS) (47, XXY). We identified 64 males with FMR1 methylation and, after confirmatory testing, found seven to have full-mutation FXS and 57 to have KS. Because the precise incidence of KS is known, we used our observed KS incidence as a sentinel to assess ascertainment quality and showed that our KS incidence of 1 in 633 newborn males was not significantly different from the literature incidence of 1 in 576 (p = 0.79). The seven FXS males revealed an FXS incidence in males of 1 in 5161 (95% confidence interval of 1 in 10,653-1 in 2500), consistent with some earlier indirect estimates. Given the trials now underway for possible FXS treatments, this method could be used in newborn or infant screening as a way of ensuring early interventions for FXS.

 

Author information

Author/s: Coffee, Bradford (B); Keith, Krayton (K); Albizua, Igor (I); Malone, Tamika (T); Mowrey, Julie (J); Sherman, Stephanie L (SL); Warren, Stephen T (ST);

Affiliation: Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.

Grants: HD020521 (Agency:NICHD NIH HHS) ; HD024064 (Agency:NICHD NIH HHS) ; MM-0937-06/06 (Agency:PHS HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

Journal: American journal of human genetics (Am J Hum Genet), published in United States. (Language: eng)

Reference: 2009-Oct; vol 85 (issue 4) : pp 503-14

Dates: Created 2009/10/06; Completed 2009/10/27;

PMID: 19804849, status: MEDLINE (last retrieved date: 10/27/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: DNA Primers (0) ; FMR1 protein, human (0) ; Fragile X Mental Retardation Protein (139135-51-6) ; DNA (9007-49-2)

Related articles

These are the most related articles currently in our database:

See 100+ related articles.

Related Article Map

12/30/1996
12/30/2007
Higher Relevance Score (100)
Lower Relevance Score (71)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.

© Advanogy LLC 2003-2010 - All rights reserved. Terms of Use | Contact Us | Index